Fennel tea: Risk assessment of the phytogenic monosubstance estragole in comparison to the natural multicomponent mixture;Fencheltee: Risikoabschätzung der phytogenen monosubstanz estragol im vergleich zum natürlichen vielstoffgemisch

Forschende Komplementarmedizin und Klassische Naturheilkunde

Volumn 11, Issue 2, 2004, Pages 104-108

  Iten, F ^a   Saller, R ^a  

^a Stadtspital Triemli Departement fur Innere Medizin Abteilung fur Gastroenterologie   (Switzerland)

Author keywords

Estragole; Fennel; Foeniculum vulgare; Hepatocellular carcinoma; Hepatotoxicity; Herbal drugs; Herbal tea; Methylchavicol; Multicomponent mixture

Indexed keywords

ANETHOLE; ANTINEOPLASTIC AGENT; ANTIOXIDANT; CARCINOGEN; ESTRAGOLE; FENNEL EXTRACT; HERBACEOUS AGENT; NATURAL PRODUCT; SAFROLE; UNCLASSIFIED DRUG;

CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; COMPARATIVE STUDY; DRUG STRUCTURE; EPIDEMIOLOGICAL DATA; FENNEL; HUMAN; MEDICINAL PLANT; NONHUMAN; PROBABILITY; PROTECTION; REVIEW; RISK ASSESSMENT; TEA;

ANIMALS; ANISOLES; ANTIOXIDANTS; BEVERAGES; CARCINOGENS; FOENICULUM; HUMANS; MICE; PHYTOTHERAPY; PLANT EXTRACTS; RISK ASSESSMENT;

EID: 2442618333     PISSN: 14247364     EISSN: None     Source Type: Journal    
DOI: 10.1159/000078232     Document Type: Review

References (25)

1. ESCOP Monographs. The Scientific Foundation of Herbal Medicinal Products, 2nd ed. Stuttgart, Thieme, 2003.
2. Fintelmann V, Weiss R: Lehrbuch der Phytotherapie, 10. Aufl. Stuttgart, Hippokrates, 2002.
3. Wichtl M, Czygan F-C: Teedrogen und Phytopharmaka: Ein Handbuch für die Praxis auf wissenschaftlicher Grundlage, 4. Aufl. Stuttgart, Wissenschaftliche Verlagsgesellschaft, 2002.
4. Schulz V, Hänsel R: Rationale Phytotherapie, 4. Aufl. Berlin, Springer, 1999.
5. Saller R, Reichling J, Hellenbrecht D: Phytotherapie - Klinische, pharmakologische und pharmazeutische Grundlagen. Heidelberg, Haug, 1995.
6. Wichtl M: Teedrogen - Ein Handbuch für die Praxis auf wissenschaftlicher Grundlage, 2. Aufl. Stuttgart, Wissenschaftliche Verlagsgesellschaft, 1989.
7. Merfort I, Schmidt E: Säuglings- und Kindertees - Pharmakologie und Anwendung; in Saller R, Feiereis H (Hrsg): Beiträge zur Phytotherapie. München, Marseille, 1993 pp 81-92.
8. Hänsel R, Schulz V: Rationale Phytotherapie: Ratgeber für die ärztliche Praxis. Berlin, Springer, 1996.
9. Jensen-Jarolim E, Leitner A, Hirschwehr R, Kraft D, Wuthrich B, Scheiner O, Graf J, Ebner C: Characterization of allergens in Apiaceae spices: Anise, fennel, coriander and cumin. Clin Exp Allergy 1997;27:1299-1306.
10. Thomas A, George V, Zeise L, Sandy MS., Wang Y: Evidence on the carcinogenicity of estragole. Reproductive and Cancer Hazard Assessment Section, Office of Environmental Health Hazard Assessment, California Environmental Protection Agency, 1999. www.oehha.ca.gov/prop65/pdf/estragf. pdf.
11. Drinkwater NR, Miller EC, Miller JA, Pitot HC: Hepatocarcinogenicity of estragole (1-allyl-4-methoxybenzene) and 1′- hydroxyestragole in the mouse and mutagenicity of 1′-acetoxyestragole in bacteria. J Natl Cancer Inst 1976;57:1323-1331.
12. Miller EC, Swanson AB, Phillips DH, Fletcher TL, Liem A, Miller JA: Structure-activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole. Cancer Res 1983;43:1124-1134.
13. Miller JA, Miller EC: The metabolic activation and nucleic acid adducts of naturally occurring carcinogens: Recent results with ethyl carbamate and the spice flavors safrole and estragole. Br J Cancer 1983;48:1-15.
14. Wiseman RW, Miller EC, Miller JA, Liem A: Structure-activity studies of the hepatocarcinogenicities of alkenylbenzene derivatives related to estragole and safrole on administration to preweanling male C57BL/6J x C3H/HeJ F1 mice. Cancer Res 1987;47:2275-2283.
15. European Commission Scientific Committee on Food: Opinion of the Scientific Committee on Food on estragole (1-Allyl-4-methoxybenzene). September 26, 2001. http://europa.eu.int/comm/food/fs/sc/scf/out104_en.pdf.
16. Guenthner TM, Luo G: Investigation of the role of the 2′,3′-epoxidation pathway in the bioactivation and genotoxicity of dietary allylbenzene analogs. Toxicology 2001;160:47-58.
17. Griem P, Hassauer M, Kalberlah F, Oltmanns J, Scheibner J, Schneider K, Schuhmacher-Wolz U: Quantitative Unterschiede im Fremdstoffmetabolismus zwischen Versuchstier und Mensch. Bundesanstalt für Arbeitsschutz und Arbeitsmedizin, 2002. www.baua.de/fors/fb02/fb963d_kurz.pdf.
18. Caldwell J, Sutton JD: Influence of dose size on the disposition of trans-[methoxy- 14C]anethole in human volunteers. Food Chem Toxicol 1988;26:87-91.
19. Sangster SA, Caldwell J, Hutt AJ, Anthony A, Smith RL: The metabolic disposition of [methoxy-14C]-labelled trans-anethole, estragole and p-propylanisole in human volunteers. Xenobiotica 1987;17:1223-1232.
20. Brand N: Foeniculum; in Blaschek W, Ebel S, Hackenthal E, Holzgrabe U, Keller K, Reichling J (Hrsg): Hager ROM 2002. Hagers Handbuch der Drogen und Arzneistoffe. Berlin, Springer, 2002. www.hagerrom.de.
21. Parejo I, Viladomat F, Bastida J, Rosas-Romero A, Flerlage N, Burillo J, Codina C: Comparison between the radical scavenging activity and antioxidant activity of six distilled and nondistilled mediterranean herbs and aromatic plants. J Agric Food Chem 2002;50:6882-6890.
22. Chainy GB, Manna SK, Chaturvedi MM, Aggarwal BB: Anethole blocks both early and late cellular responses transduced by tumor necrosis factor: Effect on NF-kappaB, AP-1, JNK, MAPKK and apoptosis. Oncogene 2000;19:2943-2950.
23. Shah AH, Qureshi S, Ageel AM: Toxicity studies in mice of ethanol extracts of Foeniculum vulgare fruit and Ruta chalepensis aerial parts. J Ethnopharmacol 1991;34:167-172.
24. Pound P, Ebrahim S, Sandercock P, Bracken M B, Roberts I: Where is the evidence that animal research benefits humans? BMJ 2004;328:514-517.
25. European Agency for the Evaluation of Medicinal Products: Final position paper on the use of herbal medicinal products containing estragole. www.emea.eu.int/pdfs/human/hmpwp/033803en.pdf.